SomaLogic Operating Co., Inc.
Boulder, Colorado, United States
Purpose
to develop and validate our aptamer-based tuberculosis (TB) biomarker assay for the accurate identification of persons with active TB with theh ope of providing measurable impact on disease transmission and promotion of timely access to therapy
Division
Global Health
Date
January 2012
Region Served
GLOBAL
Committed amount
$1,554,566
Grant topic
Tuberculosis
Duration (months)
52
Grantee location
Boulder, Colorado, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.